The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D Treatment
DIAVITEX
1 other identifier
interventional
80
1 country
1
Brief Summary
The purpose of this study protocol is to assess the effect of concurrent aerobic and resistance training in patients with type 2 diabetes on vitamin D treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes-mellitus-type-2
Started Oct 2025
Typical duration for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2023
CompletedFirst Posted
Study publicly available on registry
October 13, 2023
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
ExpectedAugust 6, 2025
May 1, 2025
3 months
July 6, 2023
August 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Change in Homeostatic Model Assessment of Insulin Resistance (HOMA IR)
HOMA-IR index will be calculated by using formula (HOMA-IR=fasting glucose in mmol/l\*fasting insulin in μU/ml/22.5) to determine insulin resistance
Beginning of the study and after 4 months
Change in Homeostasis model assessment of β-cell function (HOMA-β)
The HOMA-B index will be used to quantify the pancreatic beta cells function (HOMA-B360 x fasting insulin (μU/mL) / (fasting glucose (mg/dL) - 63)).
Beginning of the study and after 4 months
Change in serum levels of Hemoglobin A1c.
Serum levels of hemoglobin A1c will be tested in the laboratory from blood draws conducted at initial visit from a fasting blood sample.
Beginning of the study and after 4 months
Change in serum lipid profile
Total cholesterol and High-density lipoprotein (HDL) cholesterol and triglyceride levels (mg/dL). Analysis ill be performed by the fully automatic Mindray BS380 using photometry-fixed time and point turbidimetry.
Beginning of the study and after 4 months
Change in weight
Anthropometric measurements (weight in kilograms)
Beginning of the study and after 4 months
Change in waist circumference
Anthropometric measurements (waist circumference in centimetre)
Beginning of the study and after 4 months
Change in Body Mass Index (BMI)
(BMI \[weight and height will be combined to report BMI\] in kg/m2
Beginning of the study and after 4 months
Vitamin D
Determination of Vitamin D levels in blood (ng/mL)
Beginning of the study
Vitamin D
Determination of Vitamin D levels in blood (ng/mL)
End of the study (4 Months)
Secondary Outcomes (7)
Sociodemographic data
Beginning of the study
Activity degree
Beginning of the study
Activity degree
End of the study (4 Months)
Psychological Well-being
Beginning of the study
Psychological Well-being
End of the study (4 Months)
- +2 more secondary outcomes
Study Arms (4)
Vitamin D treatment and training
EXPERIMENTALSubjects are type 2 diabetic patients on vitamin D treatment that will recieve a sarcoplasma stimulating training program. This program will run for 16 weeks and three sessions a week. This exercise plan is designed in three 5-week periods and a familiarization week session. In the first intervention week, the movements are as follows: 4 sets of eight repetitions with 20 seconds interval of rest between sets will be performed, with 60% of maximum repetitions. In the second week, with increasing intensity, the exercise will be performed with 60% 1RM. The third week, each movement will be performed in 5 sets with 6 repetitions with 20 seconds of rest between Hursts as an interval with 60% of maximum repetitions.
No vitamin D and training
ACTIVE COMPARATORThis will include type 2 diabetic patients not being treated with vitamin D. Sarcoplasm stimulating training system will be performed. This program will run for 16 weeks and three sessions a week. This exercise plan is designed in three 5-week periods plus a familiarization session. In the first week of intervention, the movements are as follows: 4 sets of eight repetitions with 20 seconds interval of rest between sets will be performed, with 60% of maximum repetitions. In the second week, with increasing intensity, the exercise will be performed with 60% 1RM. The third week, each movement will be performed in 5 sets with 6 repetitions with 20 seconds of rest between Hursts as an interval with 60% of maximum repetitions.
Vitamin D treatment and no traininig
NO INTERVENTIONSubjects are type 2 diabetic patients on vitamin D treatment. In this group, no exercise program will be performed.
No Vitamin D and no training
NO INTERVENTIONSubjects are type 2 diabetic patients with no vitamin D treatment and no exericse program
Interventions
Sarcoplasm stimulating training system. This program will run for a total of 16 weeks and three sessions a week. This exercise plan is designed in three 5-week periods plus a familiarization session.
Eligibility Criteria
You may qualify if:
- Adults (females or males) older than 18 years old with a diagnosis of T2D in the clinic database
- Patients who have been taking the combination therapy of metformin + sodium-glucose transport protein 2 inhibitors (iSGLT2), as recommended by the redGDPS 2023, with stable medication for the past 6 months.
- Diabetic patients taking prescribed VitD treatment for at least 6 months (intervention group) and diabetic patients not taking prescribed VitD (control group)
- Patients who signed the informed consent
- Patients capable of performing mild to moderate physical activity (to walk steadily and independently for at least 6 minutes)
You may not qualify if:
- Patients taking other medication different than metformin + iSGLT2 (including combinations and insulin)
- Female subjects who are pregnant
- Patients who did not sign the informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ramon Llulllead
- University of Barcelonacollaborator
- Islamic Azad University, Sanandajcollaborator
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurinacollaborator
- Institut Català de la Salutcollaborator
Study Sites (1)
CAP Sant Rafael
Barcelona, Spain
Related Publications (1)
Dardashtipour E, Canivell S, Azarbayjani MA, Fuente-Vidal A, Surroca A, Gascon P, Mestres C, Anton A, Pena-Mateo MJ, Carrillo-Alvarez E, Canudas AM, Guerra-Balic M, Montane J. The effect of aerobic and resistance training in patients with type 2 diabetes on vitamin D (DIAVITEX): a study protocol. Front Public Health. 2026 Jan 5;13:1674293. doi: 10.3389/fpubh.2025.1674293. eCollection 2025.
PMID: 41561835DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joel Montane, PhD
Universitat Ramon Llull
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2023
First Posted
October 13, 2023
Study Start
October 1, 2025
Primary Completion
January 1, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
August 6, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share